Pelham, AL, United States of America

Clinton J Grubbs

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Clinton J Grubbs: Innovator in Rexinoid Compounds

Introduction

Clinton J Grubbs is a notable inventor based in Pelham, Alabama. He has made significant contributions to the field of metabolic disorders and cancer treatment through his innovative research. His work focuses on novel rexinoid compounds that have the potential to transform therapeutic approaches for various health conditions.

Latest Patents

Grubbs holds a patent for "Rexinoid compounds and methods of using rexinoid compounds for treating metabolic disorders and cancer." This patent encompasses novel rexinoid compounds and outlines methods for utilizing these compounds to address disorders such as metabolic disorders, diabetes, insulin resistance, glucose intolerance, obesity, steatosis, inflammation, and cancer. His research is pivotal in advancing treatment options for these serious health issues.

Career Highlights

Grubbs is affiliated with the UAB Research Foundation at the University of Alabama at Birmingham. His role at this esteemed institution allows him to collaborate with other leading researchers and contribute to groundbreaking studies in the field of health sciences. His dedication to innovation is evident in his focused research on rexinoid compounds.

Collaborations

Some of Grubbs' notable coworkers include Jeonga Kim and Donald D Muccio. Their collaborative efforts enhance the research environment and foster the development of new therapeutic strategies.

Conclusion

Clinton J Grubbs is a distinguished inventor whose work on rexinoid compounds holds promise for treating metabolic disorders and cancer. His contributions to the field are invaluable and reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…